Secondly, its important to realise that even if the ALA/ALC combination is eventually proven to slow down or reverse mitochondrial decline, the evidence suggests this will not lead to sudden and dramatic improvements in performance
10.1111/j.1742-1241.2011.02656.x Summary Keywords incretin hormones, GLP-1 receptor agonists, DPP-4 inhibitors, cardiovascular outcomes trials, clinical trials, incretin biology, type 2 diabetes Citation Gilbert MP and Pratley RE (2020) GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials
Medication wastage and cost : Using medications outside their licensed indications may not be covered by NHS prescribing, leading to out-of-pocket expenses for patients
In addition, GLP-1 RAs were not associated with increased risk of suicide death, self-harm, or incident depression and anxiety-related disorders
One weekly injection